Tech Company Financing Transactions
Terrestrial Bio Funding Round
On 11/2/2022, Terrestrial Bio raised $27 million in Series B funding from RA Capital and private investors.
Transaction Overview
Company Name
Announced On
11/2/2022
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series B
Investors
RA Capital (Lead Investor) (Mario Barro)
Proceeds Purpose
The money helped the company finally begin the first clinical trial of its technology in August.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
30 Cummings Park Dr.
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Undisclosed
Website
Email Address
Overview
Terrestrial imagines a needle-free, refrigeration-free future of administering therapeutics -- from the comfort of your home, or anywhere you go. Our Mission: Mapping a future where anyone can benefit from next-gen therapies in a convenient, patient-friendly way. We are a group of life scientists, engineers, and entrepreneurs challenging ourselves and others to create breakthrough biomedical innovation, and make it available to people everywhere.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rachel Sha
Chief Scientific Officer
Kathryn Kosuda
VP - Bus. Development
Lynda Tussey
VP - Engineering
Matthew Dirckx
VP - Manufacturing
Ray Knox
VP - Operations
Livio Valenti
VP - Product Management
John Spiridigliozzi
VP - R & D
Jonathan Kluge
VP - Regulatory Affairs
Weiner Tilsner
Browse more venture capital transactions:
Prev: 11/2/2022: Volta Greentech venture capital transaction
Next: 11/2/2022: Carta Healthcare venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs